Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 — Fairfax, Virginia

Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 is a clinical research site located in Fairfax, Virginia, United States 22030.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gaucher Disease Type 1, Gaucher Disease Type 3.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003?

Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 conducted?

Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 has 1 clinical trials on record, with 1 currently active. Their work covers Gaucher Disease Type 1, Gaucher Disease Type 3.

Is Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 accredited by Crixeo Health?

Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 840003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.